12:00 AM
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Merck Frosst Center for Therapeutic Research preclinical data

Merck Frosst researchers and colleagues published in Nature Immunology that a series of caspase inhibitors, including M-920 (L-826,920), which has broad specificity, and...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >